
The global pharmaceutical industry is experiencing growth driven by factors such as increasing chronic disease prevalence and a rising aging population. Thus, investors could consider watching top pharma stocks Dr. Reddy's Laboratories Limited (RDY), Amneal Pharmaceuticals, Inc. (AMRX), and AbbVie Inc. (ABBV).
The life sciences industry in 2024 is expected to grow with a focus on integrating real-world data, personalized medicine, and the adoption of cloud and AI technologies, including generative AI. The trends indicate advancements in clinical research, increased patient access, and enhanced efficiencies in drug development. The global pharmaceutical market is expected to grow at a CAGR of 6.1% until 2030.